Litigation Details for Newron Pharmaceuticals S.p.A v. MSN Laboratories Private Limited (D. Del. 2021)
✉ Email this page to a colleague
Newron Pharmaceuticals S.p.A v. MSN Laboratories Private Limited (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-06-10 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Plaintiff | Referred To | |
| Parties | AUROBINDO PHARMA USA INC. | ||
| Patents | 6,500,867; 8,076,515; 8,278,485; 8,283,380 | ||
| Attorneys | Richard Charles Weinblatt | ||
| Firms | Stamoulis & Weinblatt LLC | ||
| Link to Docket | External link to docket | ||
Details for Newron Pharmaceuticals S.p.A v. MSN Laboratories Private Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-06-10 | 1 | Exhibit 1-6 | . n1StS. 6,500,867 B1 12/2002 Virkki et al. 2002/00 19421…2001). of activity. See, e.g., U.S. Pat. No. 6,500,867, herein incor 10 … United States Patent (10) Patent No.: … appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below… United States Patent (10) Patent No.: | External link to document |
| 2022-05-13 | 120 | Claim Construction Chart | of U.S. Patent No. 8,076,515 (“the ’515 patent”), U.S. Patent No. 8,278,485 (“the ’485 patent”), and …and U.S. Patent No. 8,283,380 (“the ’380 patent”) for which the parties have a dispute, together with the… ’515 patent: 32-35, 40-44; ’485 record identified by patent, claim 37)…“stable dose of “a dose of ’380 patent at Abstract, 1:14- Not amenable to … proposal of this term being (’380 patent, claims nor decreased” 10:7-20, 11:9-65, | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
